If primed for the M2-phenotype in vitro using treatment with macrophage-colony stimulating factor (M-CSF), IL4, and IL13 prior to administration into the lateral ventricle ipsilateral to the ischemic lesion, MoDMs homed to the area of ischemia and promoted post-stroke recovery and improved cognition (101). Here, IL13 is linked to stroke disorder.